انسولین دگلودک/لیراگلوتاید (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "انسولین دگلودک/لیراگلوتاید" in Persian language version.

refsWebsite

Global rank Persian rank

11europa.eu

68^th place

179^th place

2nih.gov

4^th place

5^th place

2fda.gov

447^th place

382^nd place

1medicines.org.uk

3,823^rd place

1,188^th place

europa.eu

ema.europa.eu

"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Xultophy EPAR". آژانس دارویی اروپا (EMA). Retrieved 15 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

fda.gov

accessdata.fda.gov

"Xultophy 100/3.6 (insulin degludec and liraglutide) Injection". U.S. Food and Drug Administration (FDA). 27 November 2017. Retrieved 15 May 2020.
"Xultophy: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). 23 March 2020. Retrieved 15 May 2020.

medicines.org.uk

"Xultophy 100 units/ml insulin degludec + 3.6 mg/mL liraglutide solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC)". (emc). 8 October 2019. Retrieved 15 May 2020.

nih.gov

dailymed.nlm.nih.gov

"Xultophy 100/3.6 (- insulin degludec and liraglutide injection, solution". DailyMed. 15 November 2019. Retrieved 15 May 2020.
"Xultophy 100/3.6 (- insulin degludec and liraglutide injection, solution". DailyMed. 15 November 2019. Retrieved 15 May 2020.